Soleno Therapeutics Total Risk Alpha
| SLNO Stock | | | USD 33.22 -0.39 -1.16% |
The Total Risk Alpha reading for Soleno Therapeutics is computed from historical trading observations. Values reflect historical observations within the available dataset. Normalization methods and data feeds may affect reported values. Broader indicator relationships are reflected within
Equity Screeners. Soleno Therapeutics has a market cap of 1.76 B, operating margin of 44.08%, ROE of 6.01%. Review
World Market Map for a broader allocation view. Current allocation data is available for review. The allocation includes a position in Soleno Therapeutics. The position falls within the allocation view. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as
signals in inflation.
For a detailed overview of how to trade Soleno Stock, see our
How to Trade Soleno Stock guide.
Soleno Therapeutics has current Total Risk Alpha of
-0.28. The total risk alpha measures the performance of an asset by comparing its returns with those of a selected benchmark portfolio.
Total Risk Alpha | = | RFR + (ER[b] - ER[a]) | x | STD[a] / STD[b] |
| = | -0.28 | |
| ER[a] | = | Expected return on investing in Soleno Therapeutics |
| ER[b] | = | Expected return on market index or selected benchmark |
| STD[a] | = | Standard Deviation of returns on Soleno Therapeutics |
| STD[b] | = | Standard Deviation of selected market or benchmark |
| RFR | = | Risk Free Rate of return. Typically T-Bill Rate |
Total Risk Alpha Peers Comparison
Total Risk Alpha Relative To Other Indicators
Soleno Therapeutics is rated
below average in total risk alpha compared to key competitors. It is currently under evaluation in maximum drawdown compared to key competitors .
The benchmark portfolio represents the market risk matched to the total risk of the stock ETF or fund.
Compare Soleno Therapeutics to Peers
Other Technical Indicators